Silverfin false false 30/09/2024 01/10/2023 30/09/2024 Mr. W. S. C. Cartmell Mr. W. B. Cartmell 27/07/2024 21/02/2014 Ms. J. E. Cartmell Ms. L. M. Tewkesbury 22 April 2025 The principal activity of the company continued to be that of an investment and holding company. 08906859 2024-09-30 08906859 bus:Director2 2024-09-30 08906859 2023-09-30 08906859 core:CurrentFinancialInstruments 2024-09-30 08906859 core:CurrentFinancialInstruments 2023-09-30 08906859 core:ShareCapital 2024-09-30 08906859 core:ShareCapital 2023-09-30 08906859 core:SharePremium 2024-09-30 08906859 core:SharePremium 2023-09-30 08906859 core:FurtherSpecificReserve1ComponentTotalEquity 2024-09-30 08906859 core:FurtherSpecificReserve1ComponentTotalEquity 2023-09-30 08906859 core:RetainedEarningsAccumulatedLosses 2024-09-30 08906859 core:RetainedEarningsAccumulatedLosses 2023-09-30 08906859 core:SubsidiariesWithMaterialNon-controllingInterests core:CurrentFinancialInstruments 2024-09-30 08906859 core:SubsidiariesWithMaterialNon-controllingInterests core:CurrentFinancialInstruments 2023-09-30 08906859 bus:OrdinaryShareClass1 2024-09-30 08906859 2023-10-01 2024-09-30 08906859 bus:FilletedAccounts 2023-10-01 2024-09-30 08906859 bus:SmallEntities 2023-10-01 2024-09-30 08906859 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 08906859 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 08906859 bus:Director1 2023-10-01 2024-09-30 08906859 bus:Director2 2023-10-01 2024-09-30 08906859 bus:Director3 2023-10-01 2024-09-30 08906859 bus:Director4 2023-10-01 2024-09-30 08906859 2022-10-01 2023-09-30 08906859 core:Subsidiary1 2023-10-01 2024-09-30 08906859 core:Subsidiary1 1 2023-10-01 2024-09-30 08906859 core:Subsidiary1 1 2022-10-01 2023-09-30 08906859 core:Subsidiary2 2023-10-01 2024-09-30 08906859 core:Subsidiary2 1 2023-10-01 2024-09-30 08906859 core:Subsidiary2 1 2022-10-01 2023-09-30 08906859 bus:OrdinaryShareClass1 2023-10-01 2024-09-30 08906859 bus:OrdinaryShareClass1 2022-10-01 2023-09-30 iso4217:GBP xbrli:pure decimalUnit xbrli:shares

Company No: 08906859 (England and Wales)

WICKHAM LABORATORIES HOLDINGS LIMITED

Unaudited Financial Statements
For the financial year ended 30 September 2024
Pages for filing with the registrar

WICKHAM LABORATORIES HOLDINGS LIMITED

Unaudited Financial Statements

For the financial year ended 30 September 2024

Contents

WICKHAM LABORATORIES HOLDINGS LIMITED

COMPANY INFORMATION

For the financial year ended 30 September 2024
WICKHAM LABORATORIES HOLDINGS LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 30 September 2024
DIRECTORS Mr. W. S. C. Cartmell
Mr. W. B. Cartmell (Resigned 27 July 2024)
Ms. J. E. Cartmell
Ms. L. M. Tewkesbury
REGISTERED OFFICE 25 Bramley Grove
Tenterden
TN30 7FB
United Kingdom
COMPANY NUMBER 08906859 (England and Wales)
ACCOUNTANT Verallo
Century House
Wargrave Road
Henley-on-Thames
Oxfordshire
United Kingdom
RG9 2LT
WICKHAM LABORATORIES HOLDINGS LIMITED

BALANCE SHEET

As at 30 September 2024
WICKHAM LABORATORIES HOLDINGS LIMITED

BALANCE SHEET (continued)

As at 30 September 2024
Note 2024 2023
£ £
Fixed assets
Investments 3 1,508,623 1,503,709
1,508,623 1,503,709
Current assets
Debtors 4 1,529,758 1,522,917
Cash at bank and in hand 19,667 18,573
1,549,425 1,541,490
Creditors: amounts falling due within one year 5 ( 610,285) ( 570,431)
Net current assets 939,140 971,059
Total assets less current liabilities 2,447,763 2,474,768
Net assets 2,447,763 2,474,768
Capital and reserves
Called-up share capital 6 2,822,542 2,822,542
Share premium account 586,470 586,470
Fair value reserve ( 30,532 ) ( 35,446 )
Profit and loss account ( 930,717 ) ( 898,798 )
Total shareholders' funds 2,447,763 2,474,768

For the financial year ending 30 September 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Wickham Laboratories Holdings Limited (registered number: 08906859) were approved and authorised for issue by the Board of Directors on 22 April 2025. They were signed on its behalf by:

Ms. J. E. Cartmell
Director
WICKHAM LABORATORIES HOLDINGS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 September 2024
WICKHAM LABORATORIES HOLDINGS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 September 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Wickham Laboratories Holdings Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 25 Bramley Grove, Tenterden, TN30 7FB, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Group accounts exemption

Group accounts exemption s399
The Company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the Company as an individual entity and not about its group.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including directors 0 0

3. Fixed asset investments

2024 2023
£ £
Subsidiary undertakings 1,332,302 1,332,302
Other investments and loans 176,321 171,407
1,508,623 1,503,709

Investments in shares

Name of entity Registered office Class of
shares
Ownership
30.09.2024
Ownership
30.09.2023
Held
Hoeford Research Limited Flat 3, 191 Kingsway, Hove, England, BN3 4FB Ordinary 85.00% 85.00% Direct
Hoeford Business Park Limited 25 Bramley Grove, Tenterden, England, TN30 7FB Ordinary 100.00% 100.00% Direct

4. Debtors

2024 2023
£ £
Amounts owed by own subsidiaries 1,528,948 1,522,917
Accrued income 810 0
1,529,758 1,522,917

5. Creditors: amounts falling due within one year

2024 2023
£ £
Amounts owed to own subsidiaries 170 170
Accruals 125,711 85,857
Other creditors 484,404 484,404
610,285 570,431

6. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
2,822,542 Ordinary shares of £ 1.00 each 2,822,542 2,822,542